Groundbreaking comparative study reveals best treatment for diabetes - Findings point to a paradigm shift in diabetes care, ...
With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
By Athena VlachouDrugs used to treat metabolic disorders, such as Type 2 diabetes, alleviate symptoms of Alzheimer’s disease ...
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving ...
The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...
A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...
If you have type 2 diabetes or are worried about developing it, there are steps you can take to manage the condition and be ...
David Garza is one of the many Americans who is struggling with this new reality. His new job includes an insurance plan with ...
Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...
Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study ...
The City of Providence, along other municipalities and states, is taking big pharma to court over the price of insulin.